Manufacturer
Nu Vasive, IncorporatedNuVasive® Reline® System
Country / Region:United States (US)Submission type:Special
Product code NKB· 21 CFR 888.3070
Product code
NKB
21 CFR 888.3070
Cited as predicate
0
Device details
FDA 510(k) registration fields
- K number
- K161014
- Device name
- NuVasive® Reline® System
- Company
- Nu Vasive, Incorporated
- Country / Region
- United States(US)
- Product code
- NKB
- Device class
- Class 2
- Regulation number
- 21 CFR 888.3070
- Date received
- 2016-04-11
- Decision date
- 2016-09-28
- Submission type
- Special
Intended Use
When used as a pedicle screw fixation system, the NuVasive Reline System is intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of the posterior thoracic, lumbar, and sacral spine: 1.Degenerative disc disease (as defined by back pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies) 2.Degenerative spondylolisthesis with objective evidence of neurologic impairment 3. Fracture 4. Dislocation 5. Scoliosis Page | of 2 K161014 - Page 2 of 2 \ NuVasive® Reline ® System Speed of Innovation September 26, 2016 6. Kyphosis 7. Spinal tumor and/or 8. Failed previous fusion (pseudoarthrosis) When used for posterior non-cervical screw fixation in pediatric patients, NuVasive Reline System implants are indicated as an adjunct to fusion to treat adolescent idiopathic scoliosis. Additionally the NuVasive Reline System is intended to treat pediatric patients diagnosed with the following conditions: spondylolisthesis / spondylolysis, and fracture caused by tumor and/or trauma. Pediatric pedicle screw fixation is limited to a posterior approach and is intended to be used with autograft and/or allograft. The NuVasive Reline System is also indicated for the treatment of severe spondylolisthesis (Grades 3 and 4) of the L5-S1 vertebral joint in skeletally mature patients receiving fusion by autogenous bone graft, having the device fixed or attached to the lumbar and sacral spine (L3 to sacrum), with removal of the implants after attainment of a solid fusion. When used as an anterolateral non-pedicle screw system in the thoracic and lumbar spine, the NuVasive Reline System is also intended for the following indications: 1.Degenerative disc disease (as defined by back pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies) 2.Spinal stenosis 3.Spondylolisthesis 4.Spinal deformities 5. Fracture 6. Pseudoarthosis 7.Tumor resection and/or 8. Failed previous fusion In order to achieve additional levels of fixation, the Reline System rods may be connected to the Armada System. F. Technological Characteristics As was established in this submission, the subject NuVasive Reline System is substantially equivalent to other
Device Description
The NuVasive Reline System is a pedicle screw system that consists of a variety screws, hooks, rods, lock screws, transverse connectors, rod-to-rod connectors, iliac connectors and associated general instruments. Implant components are available in a variety sizes and can be rigidly locked into a variety of different configurations to suit the individual pathology and anatomical conditions of the patient. This 510(k) is to introduce sterile packaged implants to the Reline System. Indications for Use When used as a pedicle screw fixation system, the NuVasive Reline System is intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of the posterior thoracic, lumbar, and sacral spine: 1.Degenerative disc disease (as defined by back pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies) 2.Degenerative spondylolisthesis with objective evidence of neurologic impairment 3. Fracture 4. Dislocation 5. Scoliosis Page | of 2 K161014 - Page 2 of 2 \ NuVasive® Reline ® System Speed of Innovation September 26, 2016 6. Kyphosis 7. Spinal tumor and/or 8. Failed previous fusion (pseudoarthrosis) When used for posterior non-cervical screw fixation in pediatric patients, NuVasive Reline System implants are indicated as an adjunct to fusion to treat adolescent idiopathic scoliosis. Additionally the NuVasive Reline System is intended to treat pediatric patients diagnosed with the following conditions: spondylolisthesis / spondylolysis, and fracture caused by tumor and/or trauma. Pediatric pedicle screw fixation is limited to a posterior approach and is intended to be used with autograft and/or allograft. The NuVasive Reline System is also indicated for the treatment of severe spondylolisthesis (Grades 3 and 4) of the L5-S1 vertebral joint in skeletally mature patients receiving fusion by autogenous bone graft, having the device fixed or attached to the lumbar and sacral spine (L3 to sacrum), with removal of the implants after attainment of a solid fusion. When used as an anterolateral non-pedicle screw system in the thoracic and lumbar spine, the NuVasive Reline System is also intended for the following indications: 1.Degenerative disc disease (as defined by back pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies) 2.Spinal stenosis 3.Spondylolisthesis 4.Spinal deformities 5. Fracture 6. Pseudoarthosis 7.Tumor resection and/or 8. Failed previous fusion In order to achieve additional levels of fixation, the Reline System rods may be connected to the Armada System. F. Technological Characteristics As was established in this submission, the subject NuVasive Reline System is substantially equivalent to other
Summary parsed at:2026-06-24 04:01:39 UTC
